Literature DB >> 29691918

The relationships among aberrant salience, reward motivation, and reward sensitivity.

Suzanne R Neumann1, Richard J Linscott1.   

Abstract

OBJECTIVES: Change in reward processing and motivation may mediate the relationship between dopaminergic dysregulation and positive symptoms of schizophrenia. We sought to investigate the measurement of aberrant salience and its relationship with behavioural measures of reward and motivation.
METHODS: Participants (n = 82) completed measures of aberrant salience (Aberrant Salience Inventory and Salience Attribution Task), motivation (Effort Expenditure for Rewards Task), and reinforcer sensitivity (Stimulus Chase Task). Hypotheses were tested using correlation and generalised linear modelling.
RESULTS: Results indicated no relationship between aberrant salience measures. The Aberrant Salience Inventory was positively related to effort expenditure for lower less likely rewards and predicted the use of probability alone in decision-making. The only significant relationship between reward and motivation was a positive relationship between gain sensitivity and motivated behaviour for higher more likely rewards.
CONCLUSIONS: Although some support for a relationship between measures of reward motivation and aberrant salience were found, there was no evidence that the aberrant salience measures had concurrent validity. Our results suggest caution is warranted when interpreting measures of aberrant salience.
Copyright © 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  psychometrics; reward processing; schizophrenia; schizotypy; validity

Mesh:

Year:  2018        PMID: 29691918      PMCID: PMC6877145          DOI: 10.1002/mpr.1615

Source DB:  PubMed          Journal:  Int J Methods Psychiatr Res        ISSN: 1049-8931            Impact factor:   4.035


  48 in total

1.  Incentive motivation deficits in schizophrenia reflect effort computation impairments during cost-benefit decision-making.

Authors:  Gagan Fervaha; Ariel Graff-Guerrero; Konstantine K Zakzanis; George Foussias; Ofer Agid; Gary Remington
Journal:  J Psychiatr Res       Date:  2013-08-28       Impact factor: 4.791

Review 2.  Behavioral functions of nucleus accumbens dopamine: empirical and conceptual problems with the anhedonia hypothesis.

Authors:  J D Salamone; M S Cousins; B J Snyder
Journal:  Neurosci Biobehav Rev       Date:  1997-05       Impact factor: 8.989

3.  Behavioral inhibition system (BIS), behavioral activation system (BAS) and schizophrenia: relationship with psychopathology and physiology.

Authors:  Marion R M Scholten; Jack van Honk; André Aleman; René S Kahn
Journal:  J Psychiatr Res       Date:  2006-04-27       Impact factor: 4.791

4.  Modulation of impulsivity and reward sensitivity in intertemporal choice by striatal and midbrain dopamine synthesis in healthy adults.

Authors:  Christopher T Smith; Deanna L Wallace; Linh C Dang; Esther Aarts; William J Jagust; Mark D'Esposito; Charlotte A Boettiger
Journal:  J Neurophysiol       Date:  2015-12-16       Impact factor: 2.714

5.  Subjective emotional over-arousal to neutral social scenes in paranoid schizophrenia.

Authors:  Evelina Haralanova; Svetlozar Haralanov; Anna Beraldi; Hans-Jürgen Möller; Kristina Hennig-Fast
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-07-27       Impact factor: 5.270

6.  Distinct regions of anterior cingulate cortex signal prediction and outcome evaluation.

Authors:  Andrew Jahn; Derek Evan Nee; William H Alexander; Joshua W Brown
Journal:  Neuroimage       Date:  2014-03-22       Impact factor: 6.556

7.  Dopamine and the aberrant salience hypothesis of schizophrenia.

Authors:  Oliver D Howes; Matthew M Nour
Journal:  World Psychiatry       Date:  2016-02       Impact factor: 49.548

8.  Neural and behavioral correlates of aberrant salience in individuals at risk for psychosis.

Authors:  Jonathan P Roiser; Oliver D Howes; Christopher A Chaddock; Eileen M Joyce; Philip McGuire
Journal:  Schizophr Bull       Date:  2012-12-12       Impact factor: 9.306

9.  Worth the 'EEfRT'? The effort expenditure for rewards task as an objective measure of motivation and anhedonia.

Authors:  Michael T Treadway; Joshua W Buckholtz; Ashley N Schwartzman; Warren E Lambert; David H Zald
Journal:  PLoS One       Date:  2009-08-12       Impact factor: 3.240

10.  Approach, avoidance, and their conflict: the problem of anchoring.

Authors:  Neil McNaughton; Philip J Corr
Journal:  Front Syst Neurosci       Date:  2014-07-03
View more
  5 in total

1.  The relationships among aberrant salience, reward motivation, and reward sensitivity.

Authors:  Suzanne R Neumann; Richard J Linscott
Journal:  Int J Methods Psychiatr Res       Date:  2018-04-24       Impact factor: 4.035

2.  Relations Among Anhedonia, Reinforcement Learning, and Global Functioning in Help-seeking Youth.

Authors:  LeeAnn Akouri-Shan; Jason Schiffman; Zachary B Millman; Caroline Demro; John Fitzgerald; Pamela J Rakhshan Rouhakhtar; Samantha Redman; Gloria M Reeves; Shuo Chen; James M Gold; Elizabeth A Martin; Cheryl Corcoran; Jonathan P Roiser; Robert W Buchanan; Laura M Rowland; James A Waltz
Journal:  Schizophr Bull       Date:  2021-10-21       Impact factor: 7.348

3.  Electrophysiological responses to images ranging in motivational salience: Attentional abnormalities associated with schizophrenia-spectrum disorder risk.

Authors:  Elizabeth A Martin; Lilian Yanqing Li; Mayan K Castro
Journal:  Sci Rep       Date:  2020-03-12       Impact factor: 4.379

4.  Chronic psychosocial stressors are associated with alterations in salience processing and corticostriatal connectivity.

Authors:  Robert A McCutcheon; Michael A P Bloomfield; Tarik Dahoun; Mitul Mehta; Oliver D Howes
Journal:  Schizophr Res       Date:  2018-12-17       Impact factor: 4.939

5.  Latent inhibition, aberrant salience, and schizotypy traits in cannabis users.

Authors:  Christopher Dawes; Declan Quinn; Andrea Bickerdike; Cian O'Neill; Kiri T Granger; Sarah Carneiro Pereira; Sue Lynn Mah; Mark Haselgrove; John L Waddington; Colm O'Tuathaigh; Paula M Moran
Journal:  Schizophr Res Cogn       Date:  2022-01-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.